Celularity, Inc. (CELU)
1.26
+0.04
(+3.28%)
USD |
NASDAQ |
Feb 02, 16:00
1.26
0.00 (0.00%)
After-Hours: 19:59
Celularity EPS Diluted (Quarterly) : -0.8758 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Organogenesis Holdings, Inc. | 0.111 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.08M |
| Revenue (Quarterly) | 5.284M |
| Total Expenses (Quarterly) | 28.36M |
| Enterprise Value | 101.20M |
| Gross Profit Margin (Quarterly) | -8.40% |
| Profit Margin (Quarterly) | -436.7% |
| Earnings Yield | -264.4% |
| Normalized Earnings Yield | -238.74 |